“…(3) For functional validity, it is important that contrast sensitivity be tested under different conditions: for example, under day and night illumination, with and without glare (Abrahamsson & Sjöstrand, 1986). (4) For prospective vision therapeutics that will eventually treat focal retinal damage with stem cells (Bull, Johnson, & Martin, 2008; Kelley et al, 2008) or neural prosthetics (Colby, Chang, Stulting, & Lane, 2007; Dowling, 2008; Weiland, Liu, & Humayun, 2005), it will be critical to measure the progression or remediation of contrast sensitivity at isolated retinal loci. Current cards and charts are not flexible enough to adequately capture the range of normal and abnormal CSFs observed across different illumination and glare conditions, temporal frequencies, and retinal loci.…”